During membrane fission, the GTPase dynamin forms helical assemblies at the neck of membrane buds. Although it has been proposed that fission results from the constriction of the dynamin helix, new work by Bashkirov et al. (2008) and Pucadyil and Schmid (2008) unexpectedly shows that helix disassembly is also necessary for membrane fission.
On the basis of genetic analysis in the nematode Caenorhabditis elegans, it has been postulated that developmental and homeostatic programmed cell death, as it occurs in higher animals, is usually mediated by apoptosis. Apoptosis is defined by an ensemble of morphological features, including chromatin condensation and nuclear fragmentation, cell shrinkage, plasma membrane blebbing, and formation of apoptotic bodies. In contrast, necrosis fails to display a stereotyped morphology (except for the early rupture of plasma membranes) and has historically been regarded as an unregulated means of cell death that is induced by nonspecific and nonphysiological stress (Kroemer et al., 2008) . Defying this view, Hitomi et al. (2008) now report the existence of a complex molecular pathway mediating programmed necrosis that they have unraveled using a systems biology approach.
Multiple lines of evidence indicate that necrosis can be a programmed event, both in its occurrence and in its mechanism: (1) cell death with a necrotic appearance can contribute to embryonic development and adult tissue homeostasis, (2) necrotic cell death can be induced by ligands that bind to specific plasma membrane receptors, and (3) necrosis can be regulated by genetic, epigenetic, and pharmacological factors (Golstein and Kroemer, 2007) . Moreover, the inactivation of caspases causes a shift from apoptosis either to cell death morphologies with mixed necrotic and apoptotic features or to full-blown necrosis (Kroemer et al., 2008) . This proves that different cell death modalities crossregulate each other and substantiates the notion that necrosis may constitute a default cell death pathway that is unmasked when essential effectors of apoptosis are inhibited (Golstein and Kroemer, 2007) .
Recently, the term necroptosis has been used to designate one particular type of programmed necrosis that depends on the serine/threonine kinase activity of RIP1 (Kroemer et al., 2008) . Indeed, RIP1 represents the molecular target of a new class of cytoprotective agents, the necrostatins (Degterev et al., 2005) . In their current work, Hitomi et al. (2008) apply systems biology to study two specific cases of necroptosis-namely, the necrotic demise of L929 mouse fibrosarcoma cells induced either by ligation of the tumor necrosis factor (TNF) receptor or by caspase inhibition with Z-VAD.fmk [Z-Val-Ala-Asp(OMe).fluoromethylketone]. These responses were then compared with classical apoptosis in NIH 3T3 murine fibroblasts, as triggered by TNF receptor ligation. Genome-wide screens using small interfering RNAs (siRNAs) combined with multiple in silico analyses delineated a cellular signaling network that regulates necroptosis and the molecular bifurcation between necroptosis and apoptosis.
The morphological uniformity of apoptosis hides a heterogeneous array of lethal processes that differ in their molecular determinants and functional impact, leading for instance to the distinction between intrinsic (mitochondrial) and extrinsic (death receptor-mediated) apoptotic pathways (Kroemer et al., 2008) . Hence, an important problem is whether necrosis is the manifestation of a uniform process or of a collection of cell death subroutines. The pharmacological or genetic inhibition of several key enzymes has been shown to deeply affect the execution of programmed necrosis ( Figure 1 ). These include RIP1, cyclophilin D, poly(ADP-ribose) polymerase 1 (PARP-1), and apoptosisinducing factor (AIF). RIP1 kinase activity is required for death receptor-and Z-VAD.fmk-mediated necroptosis in both murine and human cells (Holler et al., 2000) , and necrostatins confer in vivo neuroprotection against ischemia, a condition that elevates necrotic stimuli such as reactive oxygen species and Ca 2+ overload (Degterev et al., 2005) . Mice lacking cyclophilin D (a mitochondrial peptidylprolyl cis-trans isomerase that contributes to the so-called permeability transition pore complex [PTPC] ) are substantially more resistant to cardiac and cerebral ischemic injury than their wild-type littermates (Nakagawa et al., 2005) . Excessive activation of the DNA repair protein PARP-1 has been implicated in necrosis triggered by alkylating DNA damage (Zong et al., 2004) . In rodent models of ischemia, neuroprotective effects are exerted by genetic inhibition of calpains (which are Ca 2+ -activated proteases) and of the caspaseindependent death effector AIF (Golstein and Kroemer, 2007) .
Some evidence suggests that these elements are deeply interconnected. RIP1 can promote the PTPC-dependent mitochondrial permeability transition ) by inducing the accumulation of pronecrotic ceramides or by binding to another PTPC component, the adenine nucleotide translocase (Golstein and Kroemer, 2007) . Moreover, Ca 2+ -activated calpains favor the release of AIF from mitochondria, as well as the spillage of lysosomal cathepsins into the cytosol (Golstein and Kroemer, 2007) . PARP-1 activation stimulates the mitochondrial release of AIF, and AIF-mediated DNA degradation further activates PARP-1 (Yu et al., 2002) , thereby engaging a vicious cycle. The implication of PARP proteins in programmed necrosis is further substantiated by the findings of Hitomi et al. (2008) , which reveal PARP-2 as one of the core regulators of necroptosis.
Mitochondrial membrane permeabilization contributes to cell death and can either derive from the mitochondrial permeability transition (which first affects the mitochondrial inner membrane) or from mitochondrial outer membrane permeabilization, which is mediated by Bax or Bak, two proapoptotic members of the Bcl-2 protein family . Reportedly, L929 cells undergoing necroptosis do not exhibit mitochondrial outer membrane permeabilization (Golstein and Kroemer, 2007) . Moreover, the knockout of ppif (the gene coding for cyclophilin D) in mice fails to prevent apoptosis that is dependent on permeabilization of the mitochondrial outer membrane (Nakagawa et al., 2005) . Nonetheless, necroptosis is linked to rapid mitochondrial dysfunction that leads to the excessive production of reactive oxygen species. Thus, it remains formally possible that a sudden breakdown of mitochondrial function (which causes a drop in intracellular ATP), perhaps sustained by excessive activation of PARP proteins (which causes the depletion of NAD + ), might account for the bioenergetic crisis that constitutes the final step of programmed necrosis.
Surprisingly, Hitomi et al. identified the BH3-only protein Bmf as a component of the core machinery for necroptosis. In healthy cells, Bmf is sequestered to cytoskeletal structures by virtue of its interaction with dynein light chain 2. Under conditions of cellular distress, the release of Bmf from this dock facilitates its interaction with (and inhibition of) the antiapoptotic proteins Bcl-2 and Bcl-X L (Puthalakath et al., 2001) . The exact molecular mechanisms by which Bmf promotes apoptosis versus necroptosis remain to be clarified. Antiapoptotic Bcl-2 proteins can suppress both apoptosis and necrosis, and inhibit both mitochondrial outer membrane permeabilization (by sequestering Bax and Bak) and the mitochondrial permeability transition (through their interaction with the PTPC) (Golstein and Kroemer, 2007; . Thus, it is tempting to speculate that Bmf (and maybe other BH3-only proteins) might promote apoptosis by relieving Bcl-2/Bcl-X L -mediated inhibition of mitochondrial outer membrane permeabilization, and necrosis by interfering with the Bcl-2/Bcl-X L -mediated blockage of the mitochondrial permeability transition (Figure 1) . Hitomi et al. (2008) failed to identify cyclophilin D (or any other protein from the PTPC) in their screen for The programmed necrosis pathway studied by Hitomi et al., termed necroptosis, centers on the activation of the serine/threonine kinase RIP1 (receptor-interacting protein kinase 1), which can be triggered in L929 murine fibrosarcoma cells by ligation of the tumor necrosis factor receptor (TNFR) or inhibition of caspases. In NIH 3T3 murine fibroblasts, TNFR activation ignites the extrinsic apoptotic pathway, which depends on caspase-8. Caspase-8-mediated degradation of RIP1 may represent one of the major molecular switches between apoptosis and necroptosis. Apoptosis and necroptosis may preferentially involve mitochondrial outer membrane permeabilization (MOMP) and the mitochondrial permeability transition (MPT), respectively. The figure has been assembled from the data reported by Hitomi et al. (2008) in this issue, as well as from previous publications on programmed necrosis. For the sake of clarity, multiple intermediate regulators of apoptosis have not been depicted. Abbreviations: AIF, apoptosis-inducing factor; ANT, adenine nucleotide translocase; Cyt c, cytochrome c; GPI, glycosylphosphatidylinositol; IFN, interferon; LMP, lysosomal membrane permeabilization; PTPC, permeability transition pore complex; ROS, reactive oxygen species; TLR, Toll-like receptor; TNFα, tumor necrosis factor α; TNFR, tumor necrosis factor receptor; Z-VAD.fmk, Z-Val-Ala-Asp(OMe).fluoromethylketone. genes involved in necroptosis. Whether this is due to methodological limitations or rather hints at a hitherto unsuspected mechanism of Bmf-dependent cell death remains to be established.
The challenge of characterizing the precise mechanisms of programmed necrosis, as well as of the molecular switches between apoptosis and necrosis, has major therapeutic implications. In some instances, the selective inhibition of necrosis (and/or the facilitation of apoptotic cell death) may limit inflammation, and hence reduce secondary tissue damage. Conversely, it may be desirable to trigger the necrotic death of cancer cells that are resistant to apoptosis. Necrostatins have proved their therapeutic potential in a murine model of stroke (Degterev et al., 2005) . Similarly, pharmacological and/or genetic inhibition of cyclophilin D, AIF, PARP-1, calpains, and cathepsins afford cytoprotection in vivo in several models of acute cell loss (Golstein and Kroemer, 2007) . Only the future will tell which among the hits identified by Hitomi et al. will serve as new targets for the therapeutic manipulation of programmed necrosis. Indeed, several of the necroptosis-relevant proteins identified, including proteins belonging to the interferon and Toll-like receptor signaling systems, have already been accused of mediating pathological cell death in vivo.
